# Study to Evaluate the Safety and the Pharmacokinetics of "UI111" and "UIC202006" Under Fed Conditions

> **NCT07691268** · PHASE1 · COMPLETED · sponsor: **Korea United Pharm. Inc.** · enrollment: 44 (actual)

## Conditions studied

- Dyslipidemia

## Interventions

- **DRUG:** Administration of UI111
- **DRUG:** Administration of UIC202006

## Key facts

- **NCT ID:** NCT07691268
- **Lead sponsor:** Korea United Pharm. Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-02-13
- **Primary completion:** 2025-03-10
- **Final completion:** 2025-03-26
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2026-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07691268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07691268, "Study to Evaluate the Safety and the Pharmacokinetics of "UI111" and "UIC202006" Under Fed Conditions". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07691268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*